Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
How Can Real-World Evidence be Communicated Compliantly to Payers or Healthcare Providers?
Session Chair(s)

Ruslan Horblyuk, PhD, MA
- Chief Strategic Consulting Officer
- AESARA, United States
This session will discuss the discourse on how real-world data could produce real-world evidence promotional communications to inform important treatment and access decisions and would meet the evidence standards of these two available FDA Guidances.
Learning Objective : Describe how real-world evidence should be designed, analyzed, and communicated compliantly to payers or healthcare providers; Discuss ways in which real-world data and real-world evidence could meet the evidence standard for compliant communications.
Speaker(s)

Industry Perspective
Stephen Shinall, PhD
- Associate Director, Regulatory Affairs, US Advertising and Promotion
- AbbVie, Inc., United States
Industry Perspective
Danny Yeh, PhD
- Senior Director, Health Policy and Systems Research, US Medical Affairs
- Genentech, A Member of the Roche Group, United States

Industry Perspective
Alicia Mack, PharmD
- Founder | and AESARA Consulting Partner
- Aleysheya, LLC | and AESARA, United States